OpenAlex
PricingAboutJobs
Log inGet started
Work

Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study

HTML

Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14258
Authors: Torben Biester, Ido Muller, Thekla von dem Berge, Eran Atlas, Revital Nimri, Moshe Phillip, Tadej Battelino, Natasa Bratina, Klemen Dovc, Markus F. Scheerer, Olga Kordonouri, Thomas Danne
Institutions: Kinderkrankenhaus auf der Bult, Schneider Children's Medical Center, Tel Aviv University, University of Ljubljana, Ljubljana University Medical Centre, AstraZeneca (Germany)
Language: English

Topic: Diabetes Management and Research
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, type 1 diabetes, SGLT2 inhibitors, nocturnal glucose, adolescents, young adults, urinary glucose excretion, insulin reduction, beta-hydroxybutyrate, glucagon, glucose-dependent insulinotropic polypeptide, mixed meal tolerance, adjunctive therapy, hypoglycemia, ketosis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3104260886
FWCI: 5.533
Cites: 30
Cited by: 65
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security